Patents by Inventor Marianne Kaup

Marianne Kaup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120064625
    Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
    Type: Application
    Filed: January 14, 2011
    Publication date: March 15, 2012
    Inventors: Catherine Taylor, Tzann-Wei Wang, Larry Petrov, John C. Carlson, Richard Narayansingh, Marianne Kaup, Dominic Cliche, John E. Thompson
  • Patent number: 7872112
    Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: January 18, 2011
    Assignee: Senesco Technologies, Inc.
    Inventors: Catherine A. Taylor, Tzann-Wei Wang, Larry Petrov, John C. Carlson, Richard Narayansingh, Marianne Kaup, Dominic Cliche, John E. Thompson
  • Publication number: 20070059831
    Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
    Type: Application
    Filed: November 13, 2006
    Publication date: March 15, 2007
    Applicant: Senesco Technologies, Inc.
    Inventors: Catherine Taylor, Tzann-Wei Wang, Larry Petrov, John Carlson, Richard Narayansingh, Marianne Kaup, Dominic Cliche, John Thompson
  • Patent number: 7166467
    Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: January 23, 2007
    Assignee: Senesco Technologies, Inc.
    Inventors: Catherine Taylor, Tzann-Wei Wang, Larry Petrov, John C. Carlson, Richard Narayansingh, Marianne Kaup, Dominic Cliche, John E. Thompson
  • Publication number: 20030064952
    Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific eIF-5A and DHS useful in such methods.
    Type: Application
    Filed: May 7, 2002
    Publication date: April 3, 2003
    Inventors: Catherine Taylor, Tzann-Wei Wang, Larry Petrov, John C. Carlson, Richard Narayansingh, Marianne Kaup, Dominic Cliche, John E. Thompson